BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

16725

532983

RPGLIFE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

RPG LIFE SCIENCES LTD performance

Today’s low

Today’s high

₹ 2213.70 ₹ 2358.50
₹ 2244.30

52 week low

52 week high

₹ 1381.00 ₹ 2974.95
₹ 2244.30

Open Price

₹ 2358.50

Prev. Close

₹ 2333.40

Volume (Shares)

18447.00

Total traded value

₹ 414.00

Upper Circuit

₹ 2800.00

Lower Circuit

₹ 1866.80

info

RPG LIFE SCIENCES LTD Share Price Update

As of the latest trading session, RPG LIFE SCIENCES LTD share price is currently at ₹ 2244.3, which is down by ₹ -89.09 from its previous closing. Today, the stock has fluctuated between ₹ 2213.70 and ₹ 2358.50. Over the past year, RPG LIFE SCIENCES LTD has achieved a return of 45.68 %. In the last month alone, the return has been 4.41 %. Read More...

RPG LIFE SCIENCES LTD fundamentals


  • Market cap (Cr)

    3,711.90

  • P/E Ratio (TTM)

    46.90

  • Beta

    0.93

  • Book Value / share

    229.38

  • Return on equity

    25.69%

  • EPS (TTM)

    57.77

  • Dividend yield

    0.71%

  • Net profit/quarter (Cr)

    34.93

info icon alternate text
  • Market cap (Cr)

    3,710.80

  • P/E Ratio (TTM)

    46.90

  • Beta

    0.88

  • Book Value / share

    229.38

  • Return on equity

    25.69%

  • EPS (TTM)

    57.77

  • Dividend yield

    0.71%

  • Net profit/quarter (Cr)

    34.93

info icon alternate text

RPG LIFE SCIENCES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Company Name Price P/E P/B Market Cap 52 Week Low/High
Company Name Price P/E P/B Market Cap 52 Week Low/High

RPG LIFE SCIENCES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
2244.30 -3.81 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 2259.40
  • 26 Days 2210.60
  • 10 Days 2229.30
  • 50 Days 2217.30
  • 12 Days 2222.80
  • 100 Days 2219.30
  • 20 Days 2211.90
  • 200 Days 2124.20
2192.93 PIVOT

First Support

2161.97

First Resistance

2215.97

Second Support

2138.93

Second Resistance

2246.93

Third Support

2107.97

Third Resistance

2269.97

RSI

51.06

ADX

23.28

MACD

-24.24

Williams % R

-39.37

Commodity Channel Index (CCI)

-8.68

Date

2025-04-17

Week

3850.00

Same Day

2713.00

Month

4930.00

1 Year

0.93

3 Year

0.78

Over 1 Month

4.41%

down

Over 1 Year

45.68%

down

Over 3 Months

5.73%

down

Over 3 Years

55.36%

down

Over 6 Months

-21.29%

down

Over 5 Years

56.23%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

RPG LIFE SCIENCES LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
0.0%
Promoter Holdings
0.0%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category

News

Left Arrow
Right Arrow

RPG LIFE SCIENCES LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Jul 2023 12.0 Final 21 Jul 2023 Equity shares
14 Jul 2022 9.6 Final 15 Jul 2022 Equity shares
13 Aug 2021 7.2 Final 17 Aug 2021 Equity shares
24 Mar 2020 4.0 Interim 26 Mar 2020 Equity shares
22 Jul 2019 2.4 Final 24 Jul 2019 Equity shares
19 Jul 2018 2.4 Final 21 Jul 2018 Equity shares
13 Jul 2017 2.8 Final 17 Jul 2017 Equity shares
22 Mar 2016 1.6 Interim 24 Mar 2016 Equity shares
20 Jul 2015 0.8 Final 22 Jul 2015 Equity shares
11 Sep 2014 1.2 Final 15 Sep 2014 Equity shares
11 Sep 2014 0.8 Special 15 Sep 2014 Equity shares
11 Jul 2013 1.2 Final 15 Jul 2013 Equity shares
24 Jul 2012 0.8 Final 26 Jul 2012 Equity shares
14 Jul 2011 1.6 Final 18 Jul 2011 Equity shares
15 Jul 2010 1.44 Final 19 Jul 2010 Equity shares
30 Jul 2009 1.2 Final 01 Aug 2009 Equity shares
11 Aug 2008 1.2 Final 13 Aug 2008 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
28 Jun 2024 16.0 Final 28 Jun 2024 Equity shares
21 Jul 2023 12.0 Final 21 Jul 2023 Equity shares
14 Jul 2022 9.6 Final 15 Jul 2022 Equity shares
13 Aug 2021 7.2 Final 17 Aug 2021 Equity shares
24 Mar 2020 4.0 Interim 26 Mar 2020 Equity shares
22 Jul 2019 2.4 Final 24 Jul 2019 Equity shares
19 Jul 2018 2.4 Final 21 Jul 2018 Equity shares
13 Jul 2017 2.8 Final 17 Jul 2017 Equity shares
22 Mar 2016 1.6 Interim 24 Mar 2016 Equity shares
20 Jul 2015 0.8 Final 22 Jul 2015 Equity shares
11 Sep 2014 1.2 Final 15 Sep 2014 Equity shares
11 Sep 2014 0.8 Special 15 Sep 2014 Equity shares
11 Jul 2013 1.2 Final 15 Jul 2013 Equity shares
24 Jul 2012 0.8 Final 26 Jul 2012 Equity shares
14 Jul 2011 1.6 Final 18 Jul 2011 Equity shares
15 Jul 2010 1.44 Final 19 Jul 2010 Equity shares
30 Jul 2009 1.2 Final 01 Aug 2009 Equity shares
11 Aug 2008 1.2 Final 13 Aug 2008 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

RPG LIFE SCIENCES LTD Share Price

RPG Life Sciences Limited, formerly Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group. The Company is engaged in manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).

RPG Life Sciences Limited was incorporated on March 29, 2007 with the name 'RPG Pharmaceuticals Limited' . During the year 2007-08, as per the Scheme of Arrangement, the Company acquired the Pharmaceuticals Business of Brabourne Enterprises Limited along with all assets and liabilities pertaining to that business with effect from April 2, 2007. On February 13, 2008, the name of the Company was subsequently changed to RPG Life Sciences Limited.

During the year 2008-09, the company increased the production capacity of Bulk Drugs and Chemicals from 62 tonnes to 71 tonnes. They launched an oncology drug namely Exemestane. Also, they launched new products, namely Nufex Beta, Qugyl-O & Immunotec. In June 10, 2008, the equity shares of the company were listed on BSE and NSE with effect from June 10, 2008. In July 2008, the company commenced production in the new high capacity fermenters.

During the year 2009-10, the company strengthened their product portfolio by launching new products in the antibiotic, cardiovascular, anti-ulcerant, anti-depressant, immunosuppressant and Nephrology segments. The new products launched during the year were Demator, Sizomax, Mela, Exinia and Mofetyl S. They launched a new immunosuppressant product, Sirolimus, during the year. Also, they introduced 11 new products across several therapeutic segments.

The company plans to launch six new bulk drugs and two existing products in new markets. They also plan to file DMFs for several products in regulated and semi regulated markets. The company is having plans to set up dedicated divisions with their own sales force and portfolio of brands that will drive the business in therapeutic areas like oncology, psychiatry and diabetology.

New products launched were Demator, Sizomax, Mela, Exinia and Mofetyl S during the year 2009-10. The Company strengthened its product portfolio by launching new products in the antibiotic, cardiovascular, anti-ulcerant, anti-depressant, immunosuppressant and Nephrology segments. It launched a new immunosuppressant product, Sirolimus in 2010.

New divisions were launched in highly growing chronic segments namely Cardiology and Diabetic (IMPULSE), NeurologyPsychiatry (EMPATHY) and Oncology (Neo-life). A new division ESSENTIA was also launched to cater to the Hospital sales segment in 2010-11. New products launched were Seretane 2 DT, Rabee 20, Pedimec, Minilactone, Alfalog, Demator, Naprosyn Gel, Lamotrigine dispersible tablets.

The Company sold its Biotech Unit located at Ankleshwar to M/s. Intas Pharmaceuticals Limited as a going concern in 2016-17. It acquired 7 brands from Sun Pharmaceuticals Limited, set up two new divisions viz. Urolife' catering to the urology therapy and Glodiance division catering to the Cosmetic Derma therapy in 2016-17.

In 2017-18, the Company launched brands Darbepoetin (Darba) and Rituximab (XMAB), in the post-transplant care space. Both the brands displayed robust performances in the first year of launch with Darba at third slot among competing Darbepoetin brands. Among the existing products, Immunotac and Arpimune range showed strong growth. In the Africa region, the Company expanded its business with first commercial supply in FY'18. It retained leadership position in Mauritius, through anti-diabetic range while in Egypt, immunosuppressant range remained the best alternative to the innovator brands in the post organ transplant care space.

During 2019, the Company focused on launching new products and driving active promotion in the immunosuppressant range of products and strengthened the oncology portfolio basket by introducing two new monoclonal antibodies. It launched a new product, T-JAKi (JAK Inhibitor) in the immunosuppressant range of products in Rheumatology and Gastroenterology in FY21. As a part of Life Cycle Management strategy of legacy products, Romilast BL and Aldactone T new line extensions were launched. Azoran 75 mg new line extension was launched in 2021. Naprosyn+ and Aldactone-F was launched in FY 2022.

In 2024, the Company launched a digital platform for comprehensive doctor engagement, RPGserv,' which integrates physical and digital capabilities. It increased the new launches in chronic and specialty therapies such as Cardiovascular-metabolic, Urology, Rheumatology Gastroenterology and Dermatology and by entering clinical Dermatology segments.

Parent organization Goenka R P
NSE symbol RPGLIFE
Founded 2007
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of RPG Life Sciences Ltd?

Answer Field

The share price of RPG Life Sciences Ltd for NSE is ₹ 2244.3 and for BSE is ₹ 2248.9.

What is the Market Cap of RPG Life Sciences Ltd?

Answer Field

The market cap of RPG Life Sciences Ltd for NSE is ₹ 37,11.90 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of RPG Life Sciences Ltd?

Answer Field

The 52 Week High and Low of RPG Life Sciences Ltd for NSE is ₹ 2974.95 and ₹ 1381.00 and for BSE is ₹ 2976.70 and ₹ 1382.55.

How to Buy RPG Life Sciences Ltd share?

Answer Field

You can trade in RPG Life Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for RPG Life Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 44.91%.

What is the Current Share Price of RPG Life Sciences Ltd?

Answer Field

RPG Life Sciences Ltd share price is for NSE ₹ 2244.3 & for BSE ₹ 2248.9 as on Apr 25 2025 03:30 PM.

What is the Market Cap of RPG Life Sciences Ltd Share?

Answer Field

The market cap of RPG Life Sciences Ltd for NSE ₹ 37,11.90 & for BSE ₹ 0.0 as on Apr 25 2025 03:30 PM.

What is the P/E Ratio of RPG Life Sciences Ltd Share?

Answer Field

As on Apr 25 2025 03:30 PM the price-to-earnings (PE) ratio for RPG Life Sciences Ltd share is 46.90.

What is the PB ratio of RPG Life Sciences Ltd Share?

Answer Field

As on Apr 25 2025 03:30 PM, the price-to-book (PB) ratio for RPG Life Sciences Ltd share is 229.38.

How to Buy RPG Life Sciences Ltd Share?

Answer Field

You can trade in RPG Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy RPG Life Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy RPG Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “RPG Life Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|